Evidence map›Paper›PMID 42029930›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Diagnostic value of [⁶⁸Ga]Ga-FAPI PET imaging in patients with sarcoma.

Cansu Güneren, Lebriz Uslu-Beşli, Onur Erdem Şahin, Ayşe Mine Önenerk Men, Hüseyin Pehlivanoğlu, Zeynep Hande Turna, Mahmut Kürşat Özşahin, İhsan Ahmet Güneren, Haluk Burçak Sayman

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cansu GünerenDepartment of Nuclear Medicine, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey. mdcansuguneren@gmail.com.ORCID http://orcid.org/0009-0006-6766-2166
Lebriz Uslu-BeşliDepartment of Nuclear Medicine, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-1868-3957
Onur Erdem ŞahinDepartment of Nuclear Medicine, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-2330-8078
Ayşe Mine Önenerk MenDepartment of Pathology, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-0724-0544
Hüseyin PehlivanoğluDepartment of Nuclear Medicine, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-4833-0976
Zeynep Hande TurnaDepartment of Internal Medicine, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-0558-9371
Mahmut Kürşat ÖzşahinDepartment of Orthopedics and Traumatology, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-5470-5618
İhsan Ahmet GünerenDepartment of Orthopedics and Traumatology, Prof. Dr. Cemil Taşcıoğlu City Hospital, Istanbul, Turkey.ORCID http://orcid.org/0009-0001-2059-2504
Haluk Burçak SaymanDepartment of Nuclear Medicine, Cerrahpaşa Medical Faculty, Istanbul University-Cerrahpaşa, Istanbul, Turkey.ORCID http://orcid.org/0000-0002-0954-5707

Funding

Istanbul Üniversitesi-Cerrahpasa 37751
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FAPIFDGFibroblast activation proteinPETSarcoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.